Our Vision
Bora upholds a high standard of corporate values — choosing to do what is right, not what is easy — and is committed to supplying high-quality medicines together with reliable, efficient manufacturing and services that safeguard public health worldwide.
Guided by this principle, Bora Pharmaceuticals established the Sustainability Development Committee in 2022 to realize its sustainability vision, fulfill corporate social responsibility, and strengthen governance oversight. The Committee focuses on 4 core pillars rooted in our core pharmaceutical business and aligned with the United Nations Sustainable Development Goals (SDGs), in particular SDG 3 “Good Health and Well-being”, SDG 8 “Decent Work and Economic Growth”, and SDG 12 “Responsible Consumption and Production”.
Through this framework, we continue to advance global health and well-being, build a responsible operating model, and promote sustainable industry development, creating long-term value for society while enhancing our competitiveness and expanding our positive impact as a pharmaceutical
Sustainability Objectives
Bora Pharmaceuticals defines sustainability as a core operational strategy of the Group and is committed to exerting a positive social and environmental influence. The Sustainability Development Office works with the execution teams to formulate the Group’s short-, medium-, and long-term sustainability objectives.
These objectives were discussed with the Sustainability Development Committee and the Board of Directors on November 13, 2024.
